Canndoc Product Portfolio
Chronic Pain, Chemotherapy-Induced Nausea & Vomiting, PTSD, Crohn's Disease, Parkinson's Disease, and other approved conditions
ApprovedCommercial
Key Facts
Indication
Chronic Pain, Chemotherapy-Induced Nausea & Vomiting, PTSD, Crohn's Disease, Parkinson's Disease, and other approved conditions
Phase
Approved
Status
Commercial
Company
About InterCure
InterCure is a vertically integrated medical cannabis company that develops, produces, and distributes pharmaceutical-grade cannabis products under its 'Canndoc' brand. The company is focused on clinical research, GMP compliance, and expanding its international footprint through strategic partnerships and acquisitions. As a public company on the NASDAQ and TASE, InterCure aims to establish itself as a global leader in the medical cannabis sector by providing standardized, research-backed treatments.
View full company profile